about
What we truly know about occupation as a risk factor for ALS: A critical and systematic reviewThe European Haemophilia Network (EUHANET)Large scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more.Laser-assisted endoscopic third ventriculostomy: long-term results in a series of 202 patients.Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patients.Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.Quality of haemophilia care in The Netherlands: new standards for optimal careComparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoringValidity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project.Starreveld scoring method in diagnosing childhood constipationCoping style and quality of life in patients with epilepsy: a cross-sectional study.A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.Prophylaxis for severe hemophilia: experience from Europe and the United States.Health-related quality of life as outcome parameter in haemophilia treatment.Coping style and health-related quality of life in caregivers of epilepsy patients.Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.Scoring haemophilic arthropathy on X-rays: improving inter- and intra-observer reliability and agreement using a consensus atlasTurning severe into moderate haemophilia by prophylaxis: are we reaching our goal?Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sEfficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A.Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review.Barrett's esophagus in children: does it need more attention?In-hospital rehabilitation after multiple joint procedures of the lower extremities in haemophilia patients: clinical guidelines for physical therapists.Requirements for immune recognition and processing of factor VIII by antigen-presenting cells.Health-related quality of life. The effect of pelvic floor muscle training and midurethral sling surgery: a systematic review.Models of prophylaxis.The European Principles of Haemophilia Care: a pilot investigation of adherence to the principles in Europe.Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review.Anticoagulation therapy in haemophilia. Managing the unknown.Prophylaxis in real life scenarios.Differentiating between signs of intra-articular joint bleeding and chronic arthropathy in haemophilia: a narrative review of the literature.Assessments of outcome in haemophilia - what is the added value of QoL tools?Targeting factor replacement therapy in severe hemophilia: which level is important?Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia.Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study.Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study.The burden of HCV treatment in patients with inherited bleeding disorders.
P50
Q22305680-779E6D7B-A4A2-4548-9EEB-E2B657BCE0C1Q27001556-76DDC593-8203-4F99-B775-4714B8D55232Q30234910-79791F93-3EBF-4216-B059-0A358CA5F28CQ33326545-97DDC4A9-4929-44F4-A08A-7171267B6E1BQ33496780-F484CA27-3047-4581-971A-E685EC1E6459Q33687686-A3F4B7F3-1982-4156-B8D6-EC088859A025Q33708952-39DE9839-784D-48C8-96E2-EB5106ACD2B5Q33794432-B476EE16-7515-4689-9042-25D4DBEB03A8Q34063824-296B2B4E-6739-4492-AE43-30737275CE2AQ34176938-550F43D7-CD20-4850-9336-AEAE005C4475Q34467466-C94DD8AB-8420-48E7-8D83-1128B07F93A0Q34890523-644DCFC2-9534-4B64-A84C-E92F34962DF7Q35086371-CFCD02CB-5899-4742-80A7-EF8C667BD018Q35112449-51632929-5757-4FFF-984F-60C0E2F934A3Q35249436-F9D97C0C-053B-4C0A-BE8B-819301D35B68Q36570893-F4EFAB8F-571D-4D2D-B9CF-50E7C0CD1028Q36908311-DD571F6E-A16F-448B-82B9-9B1F28678171Q37059203-5AF90123-FB26-4C6B-B683-E28B9717ED30Q37098836-CB819212-01E9-4C16-A7BE-DE0F50E9387DQ37153245-CF404ACE-D15D-463D-9633-9657B465AF96Q37634522-BB8EE254-C651-4001-B5CA-CAFE18C3B26BQ37855035-25F98F83-5A4D-401F-BCF8-B41D4D85D22DQ37860400-58BAD33D-9515-469A-A9BB-6198D42227A6Q37950693-D02480F8-3701-4866-A5CD-51EF786D47EDQ37995918-8162D626-02C7-422D-92FF-6EF2D103C879Q38020979-751F78C4-75C6-4438-A49C-565C73BA0F3FQ38038876-C6992F4B-50DF-44D9-98F7-ADDB438E16B5Q38070822-B76E219B-1144-4909-85D4-4A5631A3AD29Q38085230-150DAC56-8501-49B5-B06E-0D1460155056Q38206859-F9F2FE44-7651-473E-BF1B-54D8141CF18CQ38411798-63C765EB-BA70-43CE-868D-F4A80F19D8C2Q38511447-0087D980-70EB-40B6-8B41-F9FC476ED977Q38603033-FE84EDFB-5422-44C6-80FE-9D596781E65FQ38843540-E9573951-D94E-4C6C-9611-E6B08C215505Q39361129-726CACFC-D136-41DE-BEAF-87E8792E8E7AQ39835946-F67F2E36-8EB8-413E-BD86-0594B1AA492FQ39957037-F6A78F34-182F-47DE-943F-CBCB894AD6D3Q40013630-1847C457-75F8-4BE8-B4DB-739BEE7D4B72Q40176994-BEF8ED65-5C13-42E4-BA6A-852BE153C2DDQ40321131-36B641C2-E358-4769-8699-FF561A0589DC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kathelijn Fischer
@ast
Kathelijn Fischer
@en
Kathelijn Fischer
@es
Kathelijn Fischer
@nl
Kathelijn Fischer
@sl
type
label
Kathelijn Fischer
@ast
Kathelijn Fischer
@en
Kathelijn Fischer
@es
Kathelijn Fischer
@nl
Kathelijn Fischer
@sl
prefLabel
Kathelijn Fischer
@ast
Kathelijn Fischer
@en
Kathelijn Fischer
@es
Kathelijn Fischer
@nl
Kathelijn Fischer
@sl
P106
P21
P31
P496
0000-0001-7126-6613